Related Experiment Videos
Current treatment pathways in ALS: a South American perspective
1Centro Neurológico, Hospital Francés, School of Medicine, University of Buenos Aires, Argentina. dubro@Fibertel.com.ar
Neurology
|November 24, 1999
Summary
Diagnosing amyotrophic lateral sclerosis (ALS) in South America takes over 16 months, with limb-onset cases experiencing longer delays than bulbar-onset. Early neurologist consultation significantly speeds up ALS diagnosis.
Area of Science:
- Neurology
- Clinical Diagnosis
- Amyotrophic Lateral Sclerosis Research
Background:
- Amyotrophic lateral sclerosis (ALS) diagnosis and treatment vary globally.
- Understanding diagnostic timelines is crucial for patient management.
Purpose of the Study:
- To analyze the diagnostic process for amyotrophic lateral sclerosis (ALS) in a South American patient cohort.
- To identify factors influencing the time to diagnosis in ALS patients.
Main Methods:
- Retrospective analysis of 60 South American patients with amyotrophic lateral sclerosis (ALS).
- Data collection on time from symptom onset to diagnosis, physician consultations, and diagnostic methods used.
- Comparison of diagnostic timelines based on symptom presentation (limb vs. bulbar onset).
Main Results:
- The mean time from symptom onset to ALS diagnosis was 16.6 months.
- Limb-onset ALS took longer to diagnose (17.5 months) than bulbar-onset (10.0 months).
- Patients seeing a neurologist first were diagnosed faster (88% within 14 months).
Conclusions:
- Diagnostic delays in amyotrophic lateral sclerosis (ALS) are significant in South America.
- Early specialist intervention, particularly by neurologists, can expedite ALS diagnosis.
- Variations in diagnostic timelines highlight the need for improved diagnostic pathways.